Back
Tango Therapeutics, Inc. Stock Predictions
14K Investors Got In Earlier. You Still Can.
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Sell
41
TNGX
Tango Therapeutics, Inc.
Last Price:
$8.96
Seasonality Move:
-18.06%
7 Day Trial
ALL ACCESS PASS
$
7
Share Price Moved. Momentum Hasn't Slowed.
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radiTango Therapeutics, Inc. Stock Forecast
-
Over the next 52 weeks, Tango Therapeutics, Inc. has on average historically risen by 22.3% based on the past 5 years of stock performance.
-
Tango Therapeutics, Inc. has risen higher in 3 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
-
Is Tango Therapeutics, Inc. Stock Undervalued?The current Tango Therapeutics, Inc. [TNGX] share price is $9.12. The Score for TNGX is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
-
TNGX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Tango Therapeutics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Tango Therapeutics, Inc. has on average historically risen by 22.3% based on the past 5 years of stock performance.
Tango Therapeutics, Inc. Stock Rating
Sell
41
Tango Therapeutics, Inc. (TNGX)
is a Sell
Is Tango Therapeutics, Inc. overpriced?
-
Tango Therapeutics, Inc. has risen higher in 3 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
Tango Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
tangotx.com
52-Week Data
52-Week High:
11.20
52-Week Low:
1.03
Prediction Charts
Market Cap:
1.2B
Price in USD:
9.12
Volume:
3.2M
Beta:
1.63
Technical Analysis
SMA50:
8.65
SMA100:
7.84
SMA200:
5.40
52-Wk Change:
198.04%
Stock Predictions
-
Is Tango Therapeutics, Inc. stock public?Yes, Tango Therapeutics, Inc. is a publicly traded company.
-
What is the Tango Therapeutics, Inc. stock quote today?The Tango Therapeutics, Inc. stock price is 9.12 USD today.
-
How to buy Tango Therapeutics, Inc. stock online?You can buy Tango Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Nov-25 | 9.90 | 10.57 | 10.75 | 9.90 |
| Nov-26 | 10.57 | 10.76 | 10.92 | 10.44 |
| Nov-28 | 10.93 | 10.91 | 10.97 | 10.58 |
| Dec-1 | 10.69 | 10.42 | 11.05 | 10.17 |
| Dec-2 | 10.35 | 10.08 | 10.45 | 9.84 |
| Dec-3 | 10.10 | 9.57 | 10.15 | 9.55 |
| Dec-4 | 9.50 | 9.90 | 10.22 | 9.46 |
| Dec-5 | 9.86 | 9.63 | 9.99 | 9.55 |
| Dec-8 | 9.79 | 9.60 | 9.93 | 9.45 |
| Dec-9 | 9.52 | 9.12 | 9.75 | 8.88 |
| Dec-10 | 9.12 | 9.17 | 9.34 | 9.00 |
| Dec-11 | 9.17 | 9.10 | 9.40 | 8.89 |
| Dec-12 | 9.10 | 9.35 | 9.56 | 9.04 |
| Dec-15 | 9.52 | 9.12 | 10.08 | 9.06 |
Tango Therapeutics, Inc. Earnings
Tango Therapeutics, Inc. Earnings Report: Per Share Tango Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Tango Therapeutics, Inc. Forecast Revenue Growth
Tango Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Tango Therapeutics, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.26 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.31 per share, and a decrease next year of $0.40 per share.
* Tango Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.